BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 8686363)

  • 1. [Somatostatin receptors: a new pathway into the tumor?].
    Fehmann HC; Arnold R
    Z Gastroenterol; 1996 May; 34(5):298-9. PubMed ID: 8686363
    [No Abstract]   [Full Text] [Related]  

  • 2. Indirect antiproliferative effect of the somatostatin analog octreotide on MIA PaCa-2 human pancreatic carcinoma in nude mice.
    Weckbecker G; Raulf F; Bodmer D; Bruns C
    Yale J Biol Med; 1997; 70(5-6):549-54. PubMed ID: 9825482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of somatostatin and its analog on protein tyrosine kinases activity in the rat pituitary and the murine colonic tumors.
    Pawlikowski M; Lachowicz L; Kunert-Radek J; Winczyk K; Janiszewska G; Szkudlarek J
    Biochem Biophys Res Commun; 1998 May; 246(2):375-7. PubMed ID: 9610366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of somatostatin analogs in the management of prostate cancer.
    Sinisi AA; Rossi V; Prezioso D; Notaro A; Bellastella G; Panza N; Bellastella A; Pasquali D
    J Endocrinol Invest; 2003; 26(8 Suppl):120-4. PubMed ID: 15233227
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential effects of somatostatin analogues on proliferation of murine colonic cancer cells in vitro.
    Pawlikowski M; Kunert-Radek J; Winczyk K
    Cytobios; 1997; 89(358-359):183-7. PubMed ID: 9418016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineoplastic mechanism of Octreotide action in human hepatoma.
    Chen X; Liu Z; Ai Z
    Chin Med J (Engl); 2001 Nov; 114(11):1167-70. PubMed ID: 11729512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortistatin production by HepG2 human hepatocellular carcinoma cell line and distribution of somatostatin receptors.
    Notas G; Kolios G; Mastrodimou N; Kampa M; Vasilaki A; Xidakis C; Castanas E; Thermos K; Kouroumalis E
    J Hepatol; 2004 May; 40(5):792-8. PubMed ID: 15094227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibition of activator protein-1 on the growth of gastric cancer by octreotide].
    Wang CH; Tang CW
    Ai Zheng; 2002 Aug; 21(8):850-4. PubMed ID: 12478891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Somatostatin receptors in immune system cells].
    Ferone D; Lombardi G; Colao A
    Minerva Endocrinol; 2001 Sep; 26(3):165-73. PubMed ID: 11753240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibition effects of octreotide on the growth of hepatocellular carcinoma in vitro and in vivo].
    Wang C; Tang C; Tang L
    Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1194-7. PubMed ID: 11769709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin receptor subtypes in human non-functioning neuroendocrine tumors and effects of somatostatin analogue SOM230 on cell proliferation in cell line NCI-H727.
    Ono K; Suzuki T; Miki Y; Taniyama Y; Nakamura Y; Noda Y; Watanabe M; Sasano H
    Anticancer Res; 2007; 27(4B):2231-9. PubMed ID: 17695508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel molecular aspects of pituitary adenomas.
    Hubina E; Ruscica M; Nanzer AM; Czirják S; Góth MI; Grossman AB; Korbonits M
    J Endocrinol Invest; 2005; 28(11 Suppl International):87-92. PubMed ID: 16625855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin receptors and breast cancer.
    Cameron Smith M; Orlando C; Serio M; Maggi M
    J Endocrinol Invest; 2003; 26(8 Suppl):125-30. PubMed ID: 15233228
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of somatostatin and octreotide on proliferation and vascular endothelial growth factor secretion from murine endothelial cell line (HECa10) culture.
    Lawnicka H; Stepień H; Wyczółkowska J; Kolago B; Kunert-Radek J; Komorowski J
    Biochem Biophys Res Commun; 2000 Feb; 268(2):567-71. PubMed ID: 10679244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octreotide inhibits proliferation and induces apoptosis of hepatocellular carcinoma cells.
    Liu HL; Huo L; Wang L
    Acta Pharmacol Sin; 2004 Oct; 25(10):1380-6. PubMed ID: 15456543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of octreotide on angiogenesis induced by hepatocellular carcinoma in vivo.
    Jia WD; Xu GL; Sun HC; Wang L; Xu RN; Xue Q
    Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):404-9. PubMed ID: 14599948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some changes of receptor and postreceptor signal transduction regulated by somatostatin in pituitary hGH-secreting adenomas.
    Deng J; Shi Y; Yin J
    Chin Med J (Engl); 1997 Sep; 110(9):678-81. PubMed ID: 9642323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Editor's commentary: Clinical use of somatostatin].
    Tulassay Z
    Orv Hetil; 2013 Sep; 154(39):1526. PubMed ID: 24058096
    [No Abstract]   [Full Text] [Related]  

  • 19. Paclitaxel-octreotide conjugates in tumor growth inhibition of A549 human non-small cell lung cancer xenografted into nude mice.
    Shen H; Hu D; Du J; Wang X; Liu Y; Wang Y; Wei JM; Ma D; Wang P; Li L
    Eur J Pharmacol; 2008 Dec; 601(1-3):23-9. PubMed ID: 18983839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiply radioiodinated somatostatin analogs induce receptor-specific cytotoxicity.
    Meyers MO; Anthony CT; Coy DH; Murphy WA; Drouant GJ; Fuselier J; Espenan GD; Maloney TJ; Woltering EA
    J Surg Res; 1998 May; 76(2):154-8. PubMed ID: 9698516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.